Adult familial cryptogenic fibrosing alveolitis in the United Kingdom
R P Marshall, A Puddicombe, W O Cookson, G J Laurent, R P Marshall, A Puddicombe, W O Cookson, G J Laurent
Abstract
Background: Familial cases of cryptogenic fibrosing alveolitis (CFA) have previously been reported; however, the prevalence and genetic background of this disorder are not known. The clinical and epidemiological findings of 25 families identified within the UK are reported.
Methods: Adult pulmonary physicians in the UK were asked to identify all families under their care in which two or more individuals had been diagnosed with fibrosing alveolitis of unknown cause. A detailed structured questionnaire was sent to each proband to delineate possible environmental/occupational exposures and to obtain complete pedigree data. Physicians were also asked to provide clinical and diagnostic information.
Results: Twenty five families were identified comprising 67 cases. Suitable data for analysis were available for 21 families (57 cases). The male:female ratio was 1. 75:1 (p<0.05). A high resolution computed tomographic (HRCT) scan was performed in 93% and a diagnosis of CFA confirmed on biopsy specimens in 32%. The mean age at diagnosis was 55.5 (2.5) years. Fifty percent of cases were ever smokers and 18% had been diagnosed as asthmatic. Exposure to known fibrogenic agents was recorded by 36% of patients. Clinical signs/symptoms and histological findings were indistinguishable from non-familial cases.
Conclusions: This study represents the largest cohort of familial CFA cases reported to date and confirms a prevalence of 1.34 cases per 10(6) in the UK population. Although rare, such cases represent an important subgroup in which a genetic susceptibility to pulmonary fibrosis is particularly evident. Familial patients are younger at diagnosis but otherwise indistinguishable from non-familial cases. The mode of inheritance is as yet unclear but a number of genetic loci are likely to be involved and are the subject of ongoing studies.
References
- Dis Chest. 1969 Jan;55(1):7-12
- Am Rev Respir Dis. 1983 Jan;127(1):63-6
- J Pediatr. 1984 Jun;104(6):873-6
- Eur J Clin Invest. 1985 Feb;15(1):6-14
- N Engl J Med. 1986 May 22;314(21):1343-7
- BMJ. 1990 Nov 3;301(6759):1017-21
- Pediatrics. 1959 Nov;24:786-813
- J Clin Pharmacol. 1995 Apr;35(4):351-6
- Lancet. 1996 Feb 3;347(8997):284-9
- Thorax. 1997 Jan;52(1):38-44
- Int J Biochem Cell Biol. 1997 Jan;29(1):107-20
- Dis Chest. 1950 Oct;18(4):330-44
- Blood. 1959 Feb;14(2):162-9
- Lancet. 1991 Sep 14;338(8768):661-2
Source: PubMed